| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on September 13, 2006
Accepted on January 2, 2007

3 displays cell-, TR isoform- and thyroid hormone response element specific actions
Molecular Endocrinology Group, Division of Medicine & MRC Clinical Sciences Centre, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK; Molecular Regulation and Neuroendocrinology Section, Clinical Endocrinology Branch, NIDDKD, National Institutes of Health, Bethesda, MD 20892, USA; Cancer Biomarkers Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA; Endocrinology Division, Department of Medicine, Johns Hopkins Bayview Medical Center, Baltimore, MD 21224, USA
* To whom correspondence should be addressed. E-mail: graham.williams{at}imperial.ac.uk.
The THRB gene encodes the well-described thyroid hormone (T3) receptor isoforms TR
1 and TR
2 and two additional variants TR
3 and TR
3 of unknown physiological significance. TR
1, TR
2 and TR
3 are bone fide T3 receptors that bind DNA and T3 and regulate expression of T3-responsive target genes. TR
3 retains T3 binding activity but lacks a DNA binding domain and does not activate target gene transcription. TR
3 can be translated from a specific TR
3 mRNA or is co-expressed with TR
3 from a single transcript that contains an internal TR
3 translation start site. In these studies we provide evidence that the TR
3/
3 locus is present in rat but not in other vertebrates including humans. We compared the activity of TR
3 with other TR isoforms and investigated mechanisms of action of TR
3 at specific thyroid hormone response elements (TREs) in two cell types. TR
3 was the most potent isoform but TR potency was TRE-dependent. TR
3 acted as a cell-specific and TRE-dependent modulator of TR
3 when co-expressed at low concentrations. At higher concentrations, TR
3 was a TRE-selective and cell-specific antagonist of TR
1,
1 and
3. Both TR
3 and TR
3 were expressed in the nucleus in the absence and presence of hormone and their actions were determined by cell type and TRE structure, whilst TR
3 actions were also dependent on the TR isoform with which it interacted. Analysis of these complex responses implicates a range of nuclear co-repressors and co-activators as cell-, TR isoform- and TRE-specific modulators of T3 action.
This article has been cited by other articles:
![]() |
P. J. O'Shea, C. J. Guigon, G. R. Williams, and S.-y. Cheng Regulation of Fibroblast Growth Factor Receptor-1 (Fgfr1) by Thyroid Hormone: Identification of a Thyroid Hormone Response Element in the Murine Fgfr1 Promoter Endocrinology, December 1, 2007; 148(12): 5966 - 5976. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |